COMPETENCE IN NUCLEAR MEDICINE
Deutsch
English
Français
Italiano
Anker
Inhalt Top

News

06.04.2017 16:12

IASON holds Marketing Authorization for IASOtoc® in 3 countries!

IASON proudly announces that IASOtoc®(Gallium 68Ga edotreotide), a radiopharmaceutical intended for use in positron-emission-tomography, meanwhile is available with Marketing Authorization in France, Germany and Austria. IASOtoc® is mainly used for cancer patients with neuroendocrine tumours (NET).

France: Marketing Authorization number 3400955023692(25)   received on 01-07-2016

Austria: Marketing Authorization number 437334(25)   received on 07-12-2016

Germany: Marketing Authorization number 983510000   received on 09-12-2016

Inhalt Bottom